Anna Olszewska

Anna Olszewska

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2016 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
Katarzyna Skórzyńska-DziduszkoKatarzyna Skórzyńska-Dziduszko
Katarzyna Skórzyńska-Dziduszko
ŻKŻaneta Kimber-Trojnar
Żaneta Kimber-Trojnar
JPJolanta Patro-Małysza
Jolanta Patro-Małysza
AOAnna Olszewska
Anna Olszewska
TZTomasz Zaborowski
Tomasz Zaborowski
TMTeresa Małecka-Massalska
Teresa Małecka-Massalska
Gestational diabetes mellitus (GDM) is traditionally defined as hyperglycemia first detected in pregnancy. The risk of GDM is much higher among obese women than in their lean counterparts. An excess of adipose tissue leads to immune and inflammatory responses of both white adipose tissue and the placenta, contributing to systemic inflammation. Although the significance of both obesity and inflammation is relatively well characterized in GDM, the molecular mechanisms involved are not fully defined and require further study. In recent years huge progress has been made in identifying the intracellular signaling pathways involved in the pathophysiology of GDM. However, currently available data regarding inflammation and obesity in women with GDM are still conflicting or incomplete. We discuss selected aspects of the problem and propose future directions for research in the hope of achieving a better understanding of the disease. In particular, this review highlights recent studies exploring molecular alterations related to insulin resistance, inflammation of the adipose tissue and the placenta, lipotoxicity or endotoxemia.

1 September 2018 in Polyhedron
Verified
Journal Article
Closed access
SMSimon Muche
Simon Muche
KHKlaus Harms
Klaus Harms
ABAnna Biernasiuk
Anna Biernasiuk
Anna MalmAnna Malm
Anna Malm
ŁPŁukasz Popiołek
Łukasz Popiołek
MHMałgorzata Hołyńska
Małgorzata Hołyńska

31 March 2021 in Journal of Education, Health and Sport
Verified
Journal Article
Closed access
PDF file
APAngelika Pawlak
Angelika Pawlak
GRGabriela Ręka
Gabriela Ręka
AOAnna Olszewska
Anna Olszewska
JWJoanna Warchulińska
Joanna Warchulińska
HPHalina Piecewicz-Szczęsna
Halina Piecewicz-Szczęsna
Introduction and purpose Body composition assessment is an important element in determining the health of the body, which enables us to estimate the percent content of particular tissues in the body. Measured parameters include the amount of adipose tissue, muscle, bone tissue, and hydration. The aim of the study is to present a differentiation of methods of assessing body composition and anthropometric measurements after analysis of 29 scientific publications from Pubmed and Google Scholar.A brief description of the state of knowledgeBioelectrical impedance analysis, densitometry, magnetic resonance imaging, computed tomography, and air displacement plethysmography are methods that enable us to assess body composition and hydration. These methods differ from each other in equipment which is used, accuracy, test price, and technique of measurement. The differences in the accuracy of measurements result from the lack of correlation between the methods given. Skinfold thickness, body mass index, waist to hip circumference ratio, and growth charts in children are methods of assessing anthropometric measurements. The research shows the use of individual methods of assessing body composition and methods of anthropometric measurements among different age groups.Conclusions There are many devices and methods for measuring body composition and for anthropometric measurements, which can be used in different age groups. They are important in assessing human growth, development, and health status and can be used in clinical practice.

Verified
Journal Article
Open access
PDF file
JSJustyna Sulej
Justyna Sulej
MOMonika Osińska-Jaroszuk
Monika Osińska-Jaroszuk
MJMagdalena Jaszek
Magdalena Jaszek
AOAnna Olszewska
Anna Olszewska
ABAnna Belcarz
Anna Belcarz
WPWiktoria Piątek-Gołda
Wiktoria Piątek-Gołda
Cellobiose dehydrogenase (CDH) is an extracellular hemoflavoprotein catalyzing the oxidation reaction of β-1,4-glycosidic-bonded sugars (lactose or cellobiose), which results in the formation of aldobionic acids and hydrogen peroxide as a byproduct. The biotechnological application of CDH requires the immobilization of the enzyme on a suitable support. As a carrier of natural origin used for CDH immobilization, chitosan seems to increase the catalytic potential of the enzyme, especially for applications as packaging in the food industry and as a dressing material in medical applications. The present study aimed to immobilize the enzyme on chitosan beads and determine the physicochemical and biological properties of immobilized CDHs obtained from different fungal sources. The chitosan beads with immobilized CDHs were characterized in terms of their FTIR spectra or SEM microstructure. The most effective method of immobilization in the proposed modification was the covalent bonding of enzyme molecules using glutaraldehyde, resulting in efficiencies ranging from 28 to 99%. Very promising results, compared to free CDH, were obtained in the case of antioxidant, antimicrobial, and cytotoxic properties. Summarizing the obtained data, chitosan seems to be a valuable material for the development of innovative and effective immobilization systems for biomedical applications or food packaging, preserving the unique properties of CDH.

14 May 2022 in Molecules
Verified
Journal Article
Open access
PDF file
AHAnna Horecka
Anna Horecka
MPMonika Prendecka-Wróbel
Monika Prendecka-Wróbel
LKLukasz Kurach
Lukasz Kurach
AHAnna Horecka
Anna Horecka
AOAnna Olszewska
Anna Olszewska
Jacek KurzepaJacek Kurzepa
Jacek Kurzepa
Electric cell–substrate impedance sensing is an advanced in vitro impedance measuring system which uses alternating current to determine behavior of cells in physiological conditions. In this study, we used the abovementioned method for checking the anticancer activities of betulin and betulinic acid, which are some of the most commonly found triterpenes in nature. In our experiment, the threshold concentrations of betulin required to elicit antiproliferative effects, verified by MTT and LDH release methods, were 7.8 µM for breast cancer (T47D), 9.5 µM for lung carcinoma (A549), and 21.3 µM for normal epithelial cells (Vero). The ECIS results revealed the great potential of betulin and betulinic acid’s antitumor properties and their maintenance of cytotoxic substances to the breast cancer T47D line. Moreover, both substances showed a negligible toxic effect on healthy epithelial cells (Vero). Our investigation showed that the ECIS method is a proper alternative to the currently used assay for testing in vitro anticancer activity of compounds, and that it should thus be introduced in cellular routine research. It is also a valuable tool for live-monitoring changes in the morphology and physiology of cells, which translates into the accurate development of anticancer therapies.

15 September 2015 in Advances in Clinical and Experimental Medicine
Verified
Journal Article
Open access
Katarzyna Skórzyńska-DziduszkoKatarzyna Skórzyńska-Dziduszko
Katarzyna Skórzyńska-Dziduszko
AOAnna Olszewska
Anna Olszewska
MPMonika Prendecka-Wróbel
Monika Prendecka-Wróbel
TMTeresa Małecka-Massalska
Teresa Małecka-Massalska
Advances in Clinical and Experimental Medicine jest oficjalnym pismem Uniwersytetu Medycznego im. Piast?w Sl?skich we Wroc?awiu. Publikowane s? w nim prace naukowe polskie, jak r?wnie? zagraniczne.